相关实验视频
Updated: Jan 16, 2026

09:09
In Silico Clinical Trials for Cardiovascular Disease
Published on: May 27, 2022
2.2K
心血管疾病的数字双胞胎:面向个性化和可持续的护理
1Department of Epidemiology and Public Health, Foch Hospital, Suresnes, France.
Acta cardiologica
|October 6, 2025
概括
数字双胞胎,虚拟患者复制品,提供个性化的心血管疾病 (CVD) 管理. 这项技术使量身定制的风险评估,治疗优化和主动护理成为可能,从而彻底改变了心血管医疗保健的结果.
科学领域:
- 心血管医学 心血管医学
- 医疗信息学 医疗信息学
- 计算生物学 计算生物学
背景情况:
- 心血管疾病 (CVD) 是全球主要的健康负担.
- 数字双胞胎技术,创建虚拟复制品,在医疗保健方面显示出希望.
- 整合各种数据用于特定患者的模型是CVD管理的关键.
研究的目的:
- 探索数字双胞胎在心血管疾病 (CVD) 管理中的潜在应用和好处.
- 讨论实施CVD数字双胞胎的挑战和局限性.
- 概述心血管医疗保健中数字双胞胎技术的未来方向.
主要方法:
- 这一观点综合了当前的研究和数字双胞胎在心血管疾病中的潜在应用.
- 它涉及分析患者特定计算模型的多种数据源的整合.
- 讨论包括挑战,局限性和未来的研究途径.
主要成果:
- 数字双胞胎提供个性化风险评估,疾病建模和心血管疾病治疗优化.
- 潜在的好处包括加强远程患者监测和主动护理策略.
- 实施面临的挑战需要利益相关者之间的协作努力.
结论:
- 数字双胞胎有可能通过个性化和动态的方法彻底改变心血管疾病管理.
- 克服实施挑战对于实现改善患者治疗结果至关重要.
- 人工智能的未来进步,omics数据集成和医疗保健系统集成是关键.
相关概念视频
Issues And Trends In Healthcare Delivery System
6.1K
The issues and trends in healthcare delivery are constantly changing. The COVID-19 pandemic is one recent issue that wreaked havoc on healthcare systems, causing a shortage of healthcare workers, high demand for medicines and supplies, and increased medical expenditure due to a lack of insurance. Other issues include rising healthcare costs and care fragmentation.
Cost Containment
Payment for healthcare services has historically promoted adoption of costly and often unnecessary or inefficient...
Cost Containment
Payment for healthcare services has historically promoted adoption of costly and often unnecessary or inefficient...
6.1K
Cardiomyopathy V: Interprofessional Care
338
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
338
Coronary Artery Disease V: Interprofessional Care
215
Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
215
Cardiomyopathy II: Dilated Cardiomyopathy
468
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
468
Coronary Artery Disease IV: Preventive Measures
589
Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
589
Blood Studies for Cardiovascular System I: Cardiac Biomarkers
794
Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
794

